ABBIE and CAR-T: A Powerful Combo for Safer Cancer Therapies
CAR-T cell therapy has transformed the field of oncology. By reprogramming a patient’s own T-cells to recognize and destroy cancer […]
CRISPR
SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery.
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 /Â SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in
SOHM Notes FDA’s Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development.
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in